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Background: Bioengineered plant-derived Rhamnogalacturonan-Is (RG-Is) from pectins are 
potential candidates for surface nanocoating of medical devices. It has recently been reported 
that RG-I nanocoatings may prevent bacterial infection and improve the biocompatibility of 
implants. The aim of the study was to evaluate in vitro impact of bioengineered RG-I nano-
coatings on osteogenic capacity and proinflammatory cytokine response of murine osteoblasts 
following Porphyromonas gingivalis infection.
Methods: Murine MC3T3-E1 osteoblasts and isolated primary calvarial osteoblasts from 
C57BL/6J (B6J osteoblasts) mice were infected with P. gingivalis and incubated on tissue culture 
polystyrene plates with or without nanocoatings of unmodified RG-Is isolated from potato pulps 
(PU) or dearabinanated RG-Is (PA). To investigate a behavior of infected osteoblasts cultured 
on RG-Is cell morphology, proliferation, metabolic activity, mineralization and osteogenic and 
pro-inflammatory gene expression were examined.
Results: Following P. gingivalis infection, PA, but not PU, significantly promoted MC3T3-E1 
and BJ6 osteoblasts proliferation, metabolic activity, and calcium deposition. Moreover, Il-1b, 
Il-6, TNF-α, and Rankl gene expressions were downregulated in cells cultured on PU and to 
a higher extent on PA as compared to the corresponding control, whereas Runx, Alpl, Col1a1, 
and Bglap gene expressions were upregulated vice versa.
Conclusion: Our data clearly showed that pectin RG-Is nanocoating with high content of 
galactan (PA) reduces the osteoblastic response to P. gingivalis infection in vitro and may, 
therefore, reduce a risk of inflammation especially in immunocompromised patients with 
rheumatoid or periodontal disorders.
Keywords: nanocoatings, Rhamnogalacturonan-I, Porphyromonas gingivalis, osteoblasts, 
inflammation
Introduction
The most prevalent chronic inflammatory diseases of humans are complex disorders 
of multifactorial etiology influenced by genes, environment, and their interactions. 
Periodontitis (PD) and rheumatoid arthritis (RA) are two chronic inflammatory diseases 
associated with significant morbidity and mortality, and studies have recently shown that 
they may have a bidirectional association.1,2 RA and PD have common risk factors and 
share pathogenic mechanisms related to Porphyromonas gingivalis.3–5 In PD and RA 
patients the degradation of connective and mineralized tissue is observed.6 Increased 
alveolar bone volume loss has recently been shown to be associated with the occur-
rence of a Gram-negative, black-pigmented, strict anaerobic bacterium P. gingivalis.7–9 
The pathogenic effect might be induced indirectly through multiple virulence factors, 
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such as lipopolysaccharides (LPSs), fimbriae, and proteases, 
as well as through direct interaction with the host’s soft and 
hard tissues.10 Therefore, in medically compromised patients 
where bone metabolism is affected, improvement of bone 
regeneration is needed.
Recently, it was reported that plant-derived polysac-
charides, mainly Rhamnogalacturonan-I (RG-I) pectins, 
have potential to improve bone regeneration,11–13 prevent 
inflammation,14,15 and act as a delivery mechanism for 
therapeutic agents.15 RG-I is the first molecule derived from 
plants that has been introduced and tested as a potential nano-
coating to be applied to biomaterial surfaces, for example, 
titanium, to improve bone healing and osseointegration.11,16 
RG-I is a subunit of pectin composed of a backbone of 
alternating rhamnose (Rha) and galacturonic acid (GalA) 
residues, whereas arabinian and (arabino-)galactan side 
chains are present on the rhamnosyl residues. The struc-
ture of RG-I can be enzymatically modified, which results 
in different physicochemical properties, such as total 
charge, side-chain branching, and molecular weight.11 
Well-established methods for controlling RG-Is’ structure 
modification open new possibilities for using these plant-
derived molecules as biomaterials to improve the biocompat-
ibility of medical devices.14,17
Pectins are analogs to human carbohydrates from extra-
cellular matrix (ECM), providing bio-specific cell adhesion 
and initiating bone cells activities.17 The osteoblast activity is 
essential for development, maturation, and repair of the bone. 
Osteoblastic cells differentiate from mesenchymal stem cells. 
Osteoblasts are adherent and anchorage-dependent cells, thus 
the attachment to ECM proteins, such as fibronectin, is required 
for cell differentiation. Mature osteoblasts are capable of pro-
ducing ECM through osteoid and mineralizing with Ca2+.11,17
The hypothesis is that pectin RG-I with a high amount 
of galactose (Gal RG-I) enhances osteoblasts spreading 
and growth on the surface of coated biomaterials, therefore 
stimulates bone healing. Our previous in vitro studies showed 
that pectin nanocoating with RG-Is having high content of 
galactose and low content of arabinose increased mineralized 
matrix formation of osteoblast-like cells (SaOS-2).16,18,19
RG-Is anti-inflammatory properties reported by 
Nagel et al15 and Bussy et al14 may prevent delay in bone 
regeneration connected with bacterial infection. The RG-Is 
promote B-cell proliferation and complement fixing activity, 
in addition to their stimulation of proliferation of bone 
marrow cells through the immune system.20 In addition its 
interaction with β-integrins prevents neutrophil adhesion to 
fibronectin, which represents a key step of the inflammatory 
response.21,22
Additionally, pectins are not degradable by the human 
body,11,12 relatively inexpensive, and easy to obtain in 
comparison to proteins, which are most commonly used for 
improvement of bone regeneration.23
As it is generally accepted that osteoblast activity is 
important for bone regeneration, the aim of this study was 
to evaluate the effect of RG-I nanocoating on in vitro mice 
osteoblast proliferation, metabolic activity, mineralization, 
and modulation of proinflammatory cytokine response stimu-
lated by P. gingivalis infection.
Experimental
Isolation, modification, and nanocoating 
of rg-I
RG-I from potato pulps (potato unmodified RG-I [PU]) was 
isolated according to the procedure as previously published.16 
Briefly, the enzymatic modification of potato RG-I was done 
using polygalacturonase-I (PG-I, Novozymes, Copenhagen, 
Denmark) and polygalacturonase-III (PG-III, Novozymes) 
together with pectin methylesterase (PME, Novozymes). 
The arabinose side chains of potato RG-I were removed with 
α-l-arabinofuranosidase and endo-arabinanase; galactose 
side chains were removed with β-galactosidase and endo-
β-1,4-galactanase. The chemical properties, monosaccharide 
composition, and linkage analysis of PU (unmodified) and 
potato dearabinanated RG-I (PA) (modified) have been 
presented in our previous work.16 Adherently, PU and PA 
RG-Is (128 µg/mL) were coated on the surface of 6-well, 
24-well, and 96-well tissue culture polystyrene (TCPS) 
plates (Techno Plastic Product, Trasadingen, Switzerland). 
The reaction was carried out at room temperature overnight 
in sterile conditions on the shaker (IKA-Werke GmbH & 
Co. KG, Staufen, Germany) with 100 rpm, and then the 
plates were extensively rinsed in sterile water and dried in 
a laminar flow hood before in vitro experiments. The detec-
tion of PU and PA RG-Is nanocoating was performed using 
enzyme-linked immunosorbent assay (ELISA) before and 
after in vitro tests following a procedure presented in our 
previous study.16
In vitro studies
The TCPS with PU and PA nanocoatings were tested surfaces 
and TCPS without the RG-Is were control surfaces. Mice 
osteoblast-like cells MC3T3 and primary osteoblast isolated 
from calvariae of C57BL/6J mice were cultured on tested and 
control surfaces and infected with P. gingivalis to examine 
their inflammatory response. The primary osteoblasts were 
extracted from two mice, and all in vitro experiments were 
repeated twice. The in vitro assays such as proliferation, 
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cell metabolic activity, mineralization, and gene expression 
analysis were repeated six times each (n=6).
cell culture
MC3T3-E1 osteoblast-like cells were grown in a cell culture 
medium consisting of minimum essential medium (MEM) 
(Gibco, Darmstadt, Germany), 18% fetal bovine serum (FBS) 
(Biochrom, Berlin, Germany), antibiotic (100 mg/L strepto-
mycin and 100 U/mL penicillin) (Biochrom), and 10 mL/L 
l-glutamine (Biochrom) and then incubated at 37°C with 
5% CO
2
 (Heraeus, Hanau, Germany). Primary cells (B6J 
osteoblasts) were isolated from calvariae of two C57BL/6J 
mice as described previously24 and grown in a cell culture 
medium consisting of MEM (Gibco), 10% FBS (Biochrom), 
antibiotic (100 mg/L streptomycin and 100 U/mL penicil-
lin) (Biochrom), and 10 mL/L non-essential amino acids 
(Biochrom) and then incubated at 37°C with 5% CO
2
. The 
cell morphology was observed and registered before and 
after infection with P. gingivalis by light microscopy (Leitz, 
Labovert, Germany). For proliferation assays, 1×105 cells/
mL were seeded on 96-well TCPS and cultured for 12, 24, 
48, and 72 h. For real-time polymerase chain reaction (PCR), 
5×104 cells/mL were seeded on 6-well TCPS and cultured 
for 3, 7, 14, and 21 days. For cell metabolic activity and 
mineralization, 2×104 cells/mL were seeded on 24-well TCPS 
and cultured for 3, 7, 14, and 21 days. For mineralization 
assay, the culture medium in all wells was replaced after 24 h 
with the mineralization medium additionally consisting of 
50 µL/mL ascorbic acid (Sigma-Aldrich, Seelze, Germany) 
and 10 mM glycerol 2-phosphate disodium salt hydrate 
(Sigma-Aldrich). The mineralization medium was changed 
every third day.
P. gingivalis cultivation
P. gingivalis strain ATCC 33277 (American Type Culture 
Collection, Manassas, VA, USA) examined by a microbiolog-
ical test kit ID 32A (API BioMérieux, Marcy l’Etoile, France) 
was grown anaerobically at 37°C on Columbia agar (Sifin 
Diagnostics GmbH, Berlin, Germany) containing 5% sheep 
blood (Acila Sarl, Weiterstadt, Germany), 0.1% vitamin K 
(Sigma-Aldrich, Seelze, Germany), and 0.25% hemin (Fisher 
Scientific GmbH, Schwerte, Germany) for 3–5 days.
P. gingivalis infection assay
P. gingivalis strain was resuspended in the Alpha MEM 
(Gibco) containing no antibiotics. The number of bacteria 
was determined using an UV–visible spectrophotometer 
(Shimadzu Co., Kyoto, Japan) at an optical density of 520 nm, 
based on a standard curve established by colony formation on 
bacterial plates. A multiplicity of infection of 100 was used 
to infect B6J and MC3T3-E1 osteoblasts. Briefly, conflu-
ent osteoblast monolayers were infected with P. gingivalis 
and incubated for 2 h (at 37°C in 5% CO
2
). After incuba-
tion of bacteria with the osteoblast cells, the supernatant 
was replaced with a fresh medium containing 0.5 mg/mL 
gentamicin (Biochrom) and 0.1 mg/mL metronidazole 
(Sigma-Aldrich, Munich, Germany) for 1 h in order to elimi-
nate remaining extracellular (EC) bacteria. After 1 h, the B6J 
and MC3T3-E1 osteoblast cultures were washed twice with 
sterile phosphate buffered saline (PBS), and fresh MEM 
containing FBS and antibiotics were applied to each well. 
The infected cells were incubated under standard conditions 
(at 37°C in 5% CO
2
) for in vitro experiments.
Proliferation
Cell proliferation was performed using bromodeoxyuridine 
(BrdU). The BrdU incorporated into new synthesized DNA 
was quantified after 12, 24, 48, and 72 h. Briefly, BrdU 
(Roche Diagnostics GmbH, Mannheim, Germany) was 
applied to the culture medium and incubated (37°C, 5% CO
2
). 
After 2 h, the medium was discarded and the cells were fixed 
in 70% ethanol for 30 min. Ethanol was removed by drying. 
The fixed cells were incubated with an anti-BrdU antibody 
for 2 h. The absorbance from each well was measured using 
the Microplate Reader 500 at 450 nm. The wells without cells 
containing culture medium, BrdU, and anti-BrdU antibody 
served as blank control for unspecific binding to the wells. 
The wells with cells incubated with anti-BrdU antibody for 
unspecific binding to the cells were used as a background 
control. The wells without cells containing only the culture 
medium were used as a blank; wells with cells incubated with 
the anti-BrdU antibody for unspecific binding were used as a 
background and were subtracted from all measurements.
Cell metabolic activity and mineralization assay
Cell metabolic activity using water-soluble tetrazolium salt 
(WST-1) and mineralization with Alizarin Red-S (AR-S) 
assays were performed at the same time in parallel. For 
assessing the cell metabolic activity assay, the culture 
medium was removed after 3, 7, 14, 21 days, and the 
experimental medium containing 10% (100 µL) WST-1 
reagent (Roche, Hvidovre, Denmark) was added (250 µL/
well). The plates were incubated at 37°C with 5% CO
2
 for 
1 h and 100 µL/well was transferred to a 96-well ELISA 
plate (Nunc, Roskilde, Denmark). The plate was shaken 
before readings, at 450 and 650 nm (baseline correction), 
by a Microplate Reader 500. Wells containing the WST-1 
medium without cells were used as a background and were 
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subtracted from all measurements. For the mineralization, the 
cells were fixed in ice-cold 70% ethanol (1 mL/well) for 1 h 
at 4°C. The wells were washed with 1 mL distilled water, and 
cell mineral matrix was stained with 500 µL, 40 mM AR-S 
(Sigma-Aldrich), at pH 4.2 for 10 min at room temperature 
with shaking rotation of 100 rpm. The wells were washed 
three times with 1 mL distilled water and finally washed with 
1 mL PBS with calcium and magnesium (PBS+, Biochrom) 
for 15 min at room temperature with shaking rotation of 100 
rpm to reduce nonspecific AR-S staining. Cell mineral matrix 
was distained in 500 µL 10% cetylpyridinium chloride (CPC) 
(Sigma-Aldrich), for 15 min at room temperature with rota-
tion of 100 rpm. Standard dilution and AR-S-extracts were 
applied (200 µL/well) into a 96-well ELISA plate, and AR-S 
concentrations were determined at 562 nm by a Microplate 
Reader 500. Measurements were performed using 650 nm as 
a reference. Additionally, standards were applied, 1.0 mM 
AR-S (Sigma-Aldrich) and 10% CPC (Sigma-Aldrich), to 
calculate the content of calcium in each well using analytical 
curve.
gene expression and real-time Pcr
The RNA isolation was carried out after 3, 7, 14, and 21 days 
using the RNeasy mini kit (Qiagen, Hilden, Germany) 
according to the procedure published previously.18 The 
reverse transcription (RT) PCR was determined using one-
step high-capacity cDNA RT kit (Applied Biosystem, Foster 
City, CA, USA). The level of gene expression was calculated 
with comparative C
t
 method (ΔΔC
t
). Results of actin beta 
(Actb) expression were used as a C
t
 
reference
 for each of sample, 
and results of investigated genes obtained for independent 
additional sample (RNA isolated from 3 days osteoblasts) 
were used as ΔC
t
 
calibrator
 
sample
.
SsoAdvanced™ Universal SYBR Green Supermix (Bio-
Rad, Munich, Germany) was used for expression of target 
genes (Table 1): osteoblast transcription factor (Runx2), alka-
line phosphate (Alpl), osteocalcin (Bglap), collagen type 1 
(Col1a1), receptor activator for nuclear factor kappa B ligand 
(Rankl), tumor necrosis factor-alpha (TNF-α), interleukin-1 
beta (Il-1b), interleukin-6 (Il-6), and actin beta (Actb) as 
endogenous control genes. Manually prepared cDNA of 
2 and 8 µL reaction mix was pipetted to each well of 96-well 
plate (Bio-Rad), according to manufacturer’s instructions, 
and analysis was performed with the CFX96 real-time PCR 
detection system (Bio-Rad).
Statistical analyses
Descriptive statistics were used and mean values were calcu-
lated. Results of the in vitro experiments were analyzed using 
one-way analysis of variance tests and Bonferroni corrections 
for multiple comparisons to controls using Statistical Package 
for the Social Sciences (SPSS) 11.5 software. A significance 
level, a P-value of 5%, was used throughout.
Results
In vitro studies
The results of all in vitro assays, proliferation, cell metabolic 
activity, mineralization, and gene expression were higher in 
MC3T3-E1 cell culture compared with primary B6J osteo-
blast cells analyzed at different time points. For B6J osteo-
blast cells, the results were presented only for one mouse, as 
no significant difference was found between mice.
Morphology of osteoblast cells
The morphology of B6J osteoblast cells after P. gingivalis 
infection is presented in Figure 1. In contact with PU, PA, 
and TCPS, infected B6J osteoblasts were elongated, but less 
aggregated on TCPS. The bacterial infection caused less 
spreading of the cells on the PU- and PA-coated surfaces 
compared to TCPS control.
Proliferation
The difference in proliferation rate over time is observed 
between cell line and primary osteoblasts after P. gingivalis 
Table 1 Characteristic of genes used for real-time PCR
Gene name Gene 
symbol
Gene 
ID
Unique assay ID Chromosome 
location
Amplicon 
length
Assay design
Actin beta Actb 11461 qMmuceD0027505 5:142904472–142904610 109 exonic
runt-related transcription factor 2 Runx2 12393 qMmucID0005205 17:44658643–44717289 118 Intron spanning
Collagen, type I, alpha 1 Col1a1 12842 qMmuceD0044222 11:94950400–94950515 86 exonic
Alkaline phosphatase Alpl 11647 qMmuCID0006482 4:137755656–137758687 180 Intron spanning
Bone gamma carboxyglutamate protein Bglap 12096 qMmuCED0041364 3:88384192–88384433 67 exonic
Tumor necrosis factor (ligand) superfamily, member 11 Tnfsf11 21943 qMmuCID0026078 14:78284239–78299916 194 Intron spanning
Tumor necrosis factor Tnf 21926 qMmuceD0004141 17:35201717–35201865 119 exonic
Interleukin-1 beta Il-1b 16176 qMmuceD0045755 2:129367975–129368089 85 exonic
Interleukin-6 Il-6 16193 qMmuCED0045760 5:30013377–30013476 70 exonic
Abbreviation: PCR, polymerase chain reaction.
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infection (Figure 2). The proliferation increased over time, 
where the lowest results were observed after 12 h and the 
highest after 72 h in both MC3T3-E1 and B6J osteoblast 
cell cultures. The proliferation of B6J osteoblast cells at 
the PA-coated surface was significantly higher (P,0.01) 
after 12 and 72 h compared to control. After 24 and 48 h, no 
significant difference between PA and control was found. 
The proliferation of MC3T3-E1 at the PA-coated surface was 
significantly higher (P,0.05) after 24 h compared to control, 
but no difference was found after 12, 48, and 72 h.
Cell metabolic activity
The results of cell metabolic activity assay (Figure 3) showed 
that after P. gingivalis infection, the cellular metabolic 
????? ????? ?????
?????? ?????? ??????
? ? ?
? ? ?
Figure 1 Representative images of B6J osteoblasts morphology after Porphyromonas gingivalis infection (A, D) on control surfaces, (B, E) on the surface coated with potato 
unmodified RG-I, and (C, F) on the surface coated with potato dearabinanated RG-I investigated with light microscopy (40×, 100×).
Abbreviation: RG-I, Rhamnogalacturonan-I.
? ?? ??
?
???
???
???
???
???
?
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????
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???
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Figure 2 Proliferation activity of B6J (A) and MC3T3-E1 osteoblast cells (B) after Porphyromonas gingivalis infection measured by the colorimetric method using 
bromodeoxyuridine after 12, 24, 48, and 72 h (mean ± seM, n=6).
Notes: The results represent absorbance values measured at 450 nm against the background control wells using 650 nm as a reference. ANOVA tests and Bonferroni 
corrections for multiple comparisons were applied. A significance level of 0.05 was used throughout the study. Significant difference between control (C) and tested samples 
(PU and Pa): *P,0.05, **P,0.01.
Abbreviations: ANOVA, analysis of variance; C, control tissue culture polystyrene surface; PA, potato dearabinanated RG-I; PU, potato unmodified RG-I; 
RG-I, Rhamnogalacturonan-I; SEM, standard error of the mean.
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activity increases over time in infected B6J osteoblasts 
and MC3T3-E1 cell cultures. For B6J osteoblast cells, 
significantly higher cellular metabolic activity (P,0.001) 
was observed at the PA-coated surface compared to control 
after 7 days, and for MC3T3-E1 osteoblast cells, signifi-
cantly higher cellular metabolic activity was at PA-coated 
surface after 3 (P,0.001) and 7 days (P,0.01). The cellular 
metabolic activity at the PU-coated surface was higher in 
MC3T3-E1 compared to control after 3 days (P,0.05).
cell mineralization
The results of the mineralization assay (Figure 4) showed 
the increase of mineralized matrix over time, and the 
highest amount was observed after 21 days for both B6J and 
? ?? ??
??
? ??????
???
???
?
??? ? ?? ?? ??????
???
???
???
???
???
???
???
???
????
???
???
???
???
???
???
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??? ? ? ?? ??????
??? ??
?
Figure 3 Cell metabolic activity of B6J (A) and MC3T3-E1 osteoblast cells (B) after Porphyromonas gingivalis infection measured by using water-soluble tetrazolium salt 
(WST-1) after 3, 7, 14, and 21 days (mean ± seM, n=6).
Notes: The results represent absorbance values measured at 450 nm against the background control wells using 650 nm as a reference. ANOVA tests and Bonferroni 
corrections for multiple comparisons were applied. A significance level of 0.05 was used throughout the study. Significant difference between control (C) and tested samples 
(PU and Pa): *P,0.05, **P,0.01, ***P,0.001.
Abbreviations: ANOVA, analysis of variance; C, control tissue culture polystyrene surface; PA, potato dearabinanated RG-I; PU, potato unmodified RG-I; 
RG-I, Rhamnogalacturonan-I; SEM, standard error of the mean.
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Figure 4 Relative mineralization of extracellular matrix measured by an AR-S staining assay after 3, 7, 14, and 21 days (mean ± seM, n=6) for B6J osteoblasts (A) and 
osteoblastic cells MC3T3-E1 (B).
Notes: results in nmol ca2+ AR-S correspond to amount of AR-S bound to 2 mol Ca2+/mol of dye in solution. ANOVA tests and Bonferroni corrections for multiple 
comparisons were applied. A significance level of 0.05 was used throughout the study. Significant difference between control (C) and tested samples (PU and PA): *P,0.05, 
***P,0.001.
Abbreviations: ANOVA, analysis of variance; AR-S, Alizarin Red-S; C, control tissue culture polystyrene surface; PA, potato dearabinanated RG-I; PU, potato unmodified RG-I; 
RG-I, Rhamnogalacturonan-I; SEM, standard error of the mean.
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MC3T3-E1 osteoblasts. The mineralization of B6J osteoblast 
cells was significantly higher at PA-coated surface compared 
to control after 3 (P,0.05), 7, 14, and 21 days (P,0.001). 
In MC3T3-E1 cell culture, the mineralization was signifi-
cantly higher at PA-coated surface compared to control after 
7, 14, and 21 days (P,0.05).
gene expression
The results of the real-time PCR measurements of gene 
expression are shown in Figures 5 and 6. Runx2, Col1a1, 
Bglap, Alpl, and Rankl gene expressions increased over 
time, from 3 to 21 days, respectively. In general, Runx2, 
Col1a1, Bglap, and Alpl gene expressions in different end-
points (3, 7, 14, and 21 days) were highest at the PA-coated 
surface in infected MC3T3-E1 and B6J osteoblast cell cul-
tures. Expression of Col1a1, Bglap, and Alpl in MC3T3-E1-
and B6J-infected osteoblasts cell cultured at PU was lower 
than PA, but higher at control TCPS surface (Figure 5).
Runx2 gene expressions in infected MC3T3-E1 and 
B6J osteoblasts cultured on the PA-coated surfaces were 
significantly different compared to those at control TCPS 
in different time endpoints as illustrated in Figure 5. In 
MC3T3-E1 and B6J osteoblast cells cultured on the surface 
coated with PU, Runx2 expression after 3, 7, 14, and 21 days 
was insignificantly upregulated compared to control TCPS. 
On surface coated with PA, Runx2 expression was signifi-
cantly upregulated after 3, 7, and 14 days (P#0.001) in B6J 
osteoblast cell culture compared to control TCPS. The results 
of Runx2 gene expression in MC3T3-E1 cell culture showed 
that there was a significant difference between PA and control 
TCPS. After 3, 7, 14, and 21 days, Runx2 expression was 
significantly higher (P#0.001 for 7 days and P#0.05 for 3, 
14, and 21 days) in cell culture on PA than a control surface. 
In B6J and MC3T3-E1 osteoblast cells cultured on the PU-
coated surface, Runx2 expression was higher compared to 
control TCPS, but no significant difference was found.
In infected B6J osteoblast cells cultured on the PA-coated 
surface, Col1a1 expression was significantly upregulated 
compared to control TCPS after 3, 7 (P,0.001), and 
21 days (P,0.05). In infected MC3T3-E1 osteoblast cells 
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Figure 5 (Continued)
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Figure 5 Real-time PCR measurements of the gene expression of Runx2, Col1a1, Alpl, Bglap, and Rankl in B6J (A) and MC3T3-E1 osteoblast cells (B) cultured on plates coated 
with PU, PA, and C after Porphyromonas gingivalis infection.
Notes: Values on the y-axis represent amplification efficiency (ΔΔct). results are mean ± SEM of six independent samples. ANOVA tests and Bonferroni corrections for 
multiple comparisons were applied. A significance level of 0.05 was used throughout the study. Significant difference between control (C) and tested samples (PU and PA): 
*P,0.05, **P,0.01, ***P,0.001.
Abbreviations: ANOVA, analysis of variance; C, control tissue culture polystyrene surface; ΔΔct, comparative ct method; PA, potato dearabinanated RG-I; PCR, polymerase 
chain reaction; PU, potato unmodified RG-I; RG-I, Rhamnogalacturonan-I; SEM, standard error of the mean.
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Figure 6 Real-time PCR measurements of the gene expression of Il-1b, Il-6, and TNF-α in B6J (A) and MC3T3-E1 osteoblast cells (B) cultured on plates coated with PU, PA, 
and c after Porphyromonas gingivalis infection.
Notes: Values on the y-axis represent amplification efficiency (ΔΔct). results are mean value ± SEM of six independent samples. ANOVA tests and Bonferroni corrections 
for multiple comparisons were applied. A significance level of 0.05 was used throughout the study. Significant difference between control (C) and tested samples (PU and 
Pa): *P,0.05, **P,0.01, ***P,0.001.
Abbreviations: ANOVA, analysis of variance; C, control tissue culture polystyrene surface; ΔΔct, comparative ct method; PA, potato dearabinanated RG-I; PCR, polymerase 
chain reaction; PU, potato unmodified RG-I; RG-I, Rhamnogalacturonan-I; SEM, standard error of the mean.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
7.
18
8.
10
8.
16
8 
on
 2
1-
Fe
b-
20
17
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine 2017:12submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
442
Meresta et al
cultured on the surface coated with PA, Col1a1 expression 
was significantly upregulated compared to control TCPS 
after 7 (P,0.001), 14 (P,0.01), and 21 days (P,0.001). On 
surface coated with PU in B6J osteoblast cell cultures, Col1a1 
expression was significantly upregulated after 3 (P,0.05) and 
7 (P,0.01) days compared to control TCPS. In MC3T3-E1 
osteoblast cells cultured on the surface coated with PU, 
Col1a1 expression was significantly higher compared to 
control TCPS after 7 (P,0.01) and 21 (P,0.001) days.
In infected B6J osteoblast cells cultured on the PA-
coated surface, Alpl gene expression was significantly 
upregulated compared to control TCPS after 3, 7, 14, and 
21 days (P,0.001). In infected MC3T3-E1 osteoblast cells 
cultured on the surface coated with PA, Alpl gene expres-
sion was significantly upregulated compared to control 
TCPS after 3 (P,0.05), 7 (P,0.001), 14 (P,0.01), and 
21 (P,0.001) days. On surface coated with PU in B6J 
osteoblast cell cultures, Alpl expression was significantly 
upregulated after 3, 7, 14, and 21 days (P,0.001) compared 
to control TCPS.
In infected B6J osteoblast cells cultured on the PA-coated 
surface, Bglap expression was significantly upregulated com-
pared to control TCPS after 3, 7, 14, and 21 days (P,0.001). 
In infected MC3T3-E1 osteoblast cells cultured on the surface 
coated with PA, Bglap expression was significantly upregu-
lated compared to control TCPS after 3, 7 (P,0.001), and 14 
(P,0.05) days. On surface coated with PU in B6J osteoblast 
cell cultures, Bglap expression was significantly upregu-
lated after 3 (P,0.001), 7 (P,0.01), 14 (P,0.001), and 21 
(P,0.05) days compared to control TCPS. In MC3T3-E1 
osteoblast cells cultured on the PU-coated surface, Bglap 
expression was significantly higher compared to control 
TCPS after 3 and 7 days (P,0.01).
The Rankl in infected B6J osteoblast cells cultured on the 
PA-coated surface was expressed significantly lower com-
pared to control TCPS after 3 (P#0.001), 7, 14 (P#0.01), 
and 21 (P#0.05) days. The Rankl in infected MC3T3-E1 
cell culture was expressed significantly lower at PA-coated 
surface compared to control TCPS after 3, 7, 14, and 21 days 
(P#0.001). For PU-coated surface, the Rankl expression 
was significantly lower in B6J osteoblast cell cultures after 3 
(P#0.01) days. In MC3T3-E1 cell cultured on the PU-coated 
surface, Rankl was downregulated compared to control after 
3 (P#0.5) and 14 (P#0.01) days.
Expression of Il-1b, Il-6, and TNF-α decreased over 
the time from 3 to 21 days, respectively. Generally, Il-1b, 
Il-6, and TNF-α expressions were lower at PA-coated surface 
and higher at control TCPS surface in infected MC3T3-E1 
and B6J osteoblast cell cultures (Figure 6).
The Il-1b in infected B6J osteoblast cells cultured on 
the PA-coated surface was significantly downregulated 
compared to control TCPS after 7, 14 (P#0.05), and 21 
(P#0.01) days. The Il-1b in infected MC3T3-E1 cell culture 
was expressed significantly lower at PA-coated surface com-
pared to control TCPS after 3 (P#0.01), 7 (P#0.05), and 14 
(P#0.001) days. For PU-coated surface the Il-1b expression 
was significantly lower in B6J osteoblast cell cultures after 
21 days (P#0.01). In MC3T3-E1 cell cultured on the PU-
coated surface Il-1b was downregulated compared to control 
TCPS after 14 days (P#0.01).
The Il-6 in infected B6J osteoblast cells cultured on the 
PA-coated surface was significantly downregulated com-
pared to control TCPS after 3, 7, 14, and 21 days (P#0.001). 
The Il-6 in infected MC3T3-E1 cell culture was expressed 
significantly lower at PA-coated surface compared to control 
TCPS after 3, 7 (P#0.01), 14 (P#0.05), and 21 (P#0.01) 
days. For PU-coated surface the Il-6 expression was signifi-
cantly lower in B6J osteoblast cell cultures after 3, 14, 21 
(P#0.001), and 7 (P#0.01) days. In MC3T3-E1 cell cultured 
on the PU-coated surface Il-6 was downregulated compared 
to control TCPS after 3 days (P#0.5).
In infected B6J osteoblast cells cultured on the PA-coated 
surface, TNF-α expression was significantly downregulated 
compared to control TCPS after 3 and 21 days (P#0.05). 
In infected MC3T3-E1 osteoblast cells cultured on the PA-
coated surface, TNF-α was expressed significantly lower 
compared to control TCPS after 3, 7 (P#0.05), 14 (P#0.001), 
and 21 (P,0.01) days. In B6J osteoblast cells cultured on the 
PU-coated surface, TNF-α expression was lower compared 
to control TCPS, but no significant difference was found. 
In MC3T3-E1 osteoblast cells cultured on the PU-coated 
surface, TNF-α expression was downregulated compared to 
control TCPS after 14 (P#0.01) and 21 (P,0.05) days.
Discussion
In the present study, the effect of surface nanocoating with 
unmodified (PU) and enzymatically modified (PA) RG-I 
on response of osteoblasts infected with P. gingivalis was 
assessed. Our in vitro results confirmed previous findings 
that the osteoblasts response to PA and PU is related to 
the RG-Is chemical structure.18,19 The chemical structure 
differences in relative amounts and lengths of side chains 
(galactose and arabinose) in RG-Is influenced osteoblast 
behavior after P. gingivalis infection. The RG-Is with lower 
content of arabinose and higher amount of galactose (PA) 
reduced proinflammatory response of activated osteoblasts 
with P. gingivalis and thereby stimulated the osteoblasts to 
produce higher amount of mineralized matrix compared to 
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the unmodified RG-Is (PU). Studies have demonstrated that 
pectin polysaccharides isolated from other sources than PUs 
are potentially immunomodulatory agents, which are able 
to suppress the proinflammatory response of different cell 
types.14,21,22 However, the present data showed, for the first 
time, the direct anti-inflammatory effect of pectin RG-I on 
P. gingivalis-infected osteoblasts.
The P. gingivalis strain ATCC 33277 was applied to 
activate osteoblasts’ inflammatory response. This strain of 
bacteria has been frequently used in invasion studies and has 
been shown to be highly invasive in culture of different cell 
types.25–31 In this study, osteoblast-like cells, MC3T3-E1 and 
primary B6J osteoblasts from mice were used to evaluate the 
capacity of modified (PA) and unmodified (PU) RG-Is to 
inhibit the gene expression of inflammatory mediators and 
to improve mineralized matrix formation following infec-
tion. According to our results, RG-Is influence osteoblast 
proliferation after infection with P. gingivalis. We found 
that there were more proliferating cells in different time 
points on the surfaces coated with PA compared to control 
TCPS surfaces, which indicates the influence of RG-Is on 
osteoblasts’ activation. Similar results have been reported by 
Gallet et al32 with murine macrophage cell line J774.2 cul-
tured on pectin MHR-α (modified hairy regions) from apple 
in the presence of bacterial LPSs. The MHR-α nanocoating 
inhibits the LPS-induced activation of macrophages.
Our study showed that RG-I pectin, especially PA, sig-
nificantly inhibited the decrease induced by P. gingivalis 
in proliferation of osteoblasts compared to control surface 
without pectins. This finding is important due to the fact that 
P. gingivalis has a direct effect on bone resorption through 
inhibition of osteoblast proliferation.10 Bone resorption is 
mediated by proinflammatory cytokines, which are produced 
and secreted by osteoblasts in response to bacterial infection. 
Inflammatory mediators, such as Il-1b, Il-6, and TNF-α, 
have been reported to inhibit osteoblastic differentiation and 
induce activation of bone-resorbing osteoclasts.33
In our study, the osteoblast differentiation, mineralized 
matrix formation, and proinflammatory cytokines produc-
tion were observed by measuring gene expression levels in 
real-time PCR, supplemented with a biochemical mineraliza-
tion assay based on Alizarin Red staining and EC calcium 
deposition at different time points (3, 7, 14, and 21 days) to 
identify the behavior of P. gingivalis-activated cells during 
the whole osteoblast lineage. The selection of time points is 
in agreement with other studies.33 According to our results, 
the amount of EC calcium deposition (Alizarin Red stain-
ing) after infection was higher on surfaces coated with PA. 
However, the Alizarin Red staining is used as a quality rather 
than a quantity biochemical mineralization assay;34 there-
fore, gene expression was included in our study to control 
mineralization on the molecular level. The results of gene 
expression indicated that RG-I pectins prevent the decrease 
in osteoblast differentiation and matrix mineralization in 
response to P. gingivalis. The previous reports showed that 
bacterial virulence factors such as LPSs potently suppressed 
osteoblast differentiation through inhibition of the Runx2 
gene expression.33 Our present data showed that PA increased 
the expression of the Runx2 gene in both MC3T3-E1- and 
primary B6J-infected osteoblasts after 3, 7, 14, and 21 days 
compared to controls. According to these observations, RG-I 
with low content of arabinose and high content of galactose 
stimulates osteoblast activity after bacterial infection in the 
early stage of differentiation. This finding is important as 
Runx2 is considered to be essential for the promotion of 
mesenchymal cells into osteoblast progenitors and upregula-
tion of osteogenic differentiation markers such as alkaline 
phosphate, osteopontin, bone sialoprotein, and osteocalcin.35 
Furthermore, we found that RG-I-coated surfaces increased 
the expression of genes related to matrix formation (Col1a1), 
matrix maturation (Alpl), and matrix mineralization (Bglap) 
in both infected MC3T3-E1 and B6J osteoblasts at differ-
ent time points, which indicates that the nanocoating might 
stimulate bone healing and osseointegration in vivo. Our 
results show that RG-I pectin significantly inhibited the 
decrease in osteoblastic maturation, differentiation, and 
mineral matrix formation following P. gingivalis infection. 
P. gingivalis is a potent stimulator of inflammatory mediators 
such as Il-1b, Il-6, and TNF-α, which induces bone resorp-
tion through activation of osteoclasts.34,36–39 Therefore, the 
level of cytokines Il-1b, Il-6, and TNF-α gene expression 
was assessed in MC3T3-E1- and B6J-infected osteoblasts 
cultured on PU and PA pectin substrates. Our results showed 
a decrease in levels of cytokines gene expression in both cell 
types grown on the surface coated with RG-Is compared to 
control at different time points. This indicated that RG-Is, 
especially pectin substratum with lower arabinose content, 
significantly inhibit the expression of inflammatory media-
tors in osteoblasts infected with P. gingivalis. This is in line 
with a study by Gallet et al32 using a murine macrophage 
cell line J774.2 cultured on pectin MHR-α from apple and 
stimulated by bacterial LPSs. The MHR-α substratum sig-
nificantly inhibits the secretion of proinflammatory TNF-α 
mediator and generation of nitrous oxide by LPS-activated 
macrophages. Therefore, RG-I nanocoatings on surfaces 
seem to reduce cytokine-mediated bone destruction following 
bacterial infection. The Rankl has been established as a key 
mediator of inflammatory bone loss.37 We found that the 
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
7.
18
8.
10
8.
16
8 
on
 2
1-
Fe
b-
20
17
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine 2017:12submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
444
Meresta et al
level of Rankl expression in MC3T3-E1- and B6J-infected 
osteoblasts cultured on the PA- and PU-coated surfaces was 
lower than control surfaces at different time points, indicat-
ing reduced osteoclastogenesis, which subsequently could 
lead to reduced bone resorption in response to P. gingivalis 
infection. Taken as a whole, our results demonstrate that 
RG-Is may affect osteoblast behavior following inflamma-
tory process, enhancing cell proliferation, differentiation, and 
mineralization of bone matrix, but also downregulating Il-1b, 
Il-6, TNF-α, and Rankl expressions in osteoblasts which 
would lead to reduced osteoclast formation.34,36–39 The in vitro 
results obtained from the current research suggest that sugar 
composition of RG-Is modulates the cell response to bacterial 
infection. The nanocoating with PA, with higher amount of 
galactose compared to PU, influenced higher proliferation 
(BrdU), mineralized matrix formation (AR-S), cell metabolic 
activity (WST-1), gene expressions of Runx2, Col1a1, Alpl, 
and Bglap, and also lower expression levels of Il-1b, Il-6, 
TNF-α, and Rankl. Our findings support the results from 
earlier studies indicating that surfaces with short arabinian 
side chains and high amount of galactose enhance osteoblast 
cells’ spreading and growth, in contrast to the RG-Is with 
high amounts of arabinian, which lead to aggregation and 
decreased proliferation.12,13,40
Nevertheless, in cell metabolic activity and proliferation, 
the significant differences between RG-I surfaces and control 
surfaces were not observed in each selected time point.18,19
The lack of significant difference can be explained by the 
fact that the RG-I in this study was adherently coated on the 
surface, not covalently. However, the most important part of 
the osseointegration process is the formation of the ECM by 
osteoblasts and the following mineralization, which in our 
studies was investigated with a cell mineralization assay and 
gene expression levels using real-time PCR.
Our findings suggest that RG-I structure stimulates prolif-
eration, metabolic activity, and mineralization of osteoblasts 
confirmed by a variety of gene expressions. The results indi-
cate that linear 1,4-linked galactans have the capacity to limit 
inflammation and promote bone healing following bacterial 
infection. It has previously been reported that galectin-3 
present in the membrane of osteoblastic cells not only binds 
specifically to galactose residues41,42 but also interacts strongly 
with pathogenic bacteria via bacterial LPSs.43,44 Therefore, it 
can be speculated that anti-inflammatory effect of RG-I pectin 
is mediated through the galectin-3 receptor. However, poten-
tial relationships as well as molecular mechanism of interac-
tions between RG-I structure and receptors in osteoblastic 
cells under P. gingivalis infection need to be investigated.
Conclusion
The plant-derived polysaccharides, especially RG-I with 
high content of galactose, influenced P. gingivalis-infected 
osteoblast morphology, proliferation, and mineralization. 
Our results indicate for the first time the capacity of RG-I 
pectins to inhibit inflammatory osteoblast response follow-
ing bacterial infection through downregulation of Il-1b, Il-6, 
and TNF-α gene expressions. The present results open new 
direction in the development of innovative pectin surface 
nanocoatings for biomaterial applications in order to reduce 
inflammatory response of osteoblasts and improve bone 
healing in immunocompromised patients with high risk for 
bacterial infection. The possible anti-inflammatory effects 
of RG-I pectins should be investigated with further in vitro 
and in vivo studies.
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